Biochemistry

  • Two professors are named Innovation Investigators, and four win Ignite Awards.

  • IMA, Intonation to collaborate

    The goal of the collaboration is to rapidly improve care for patients with tumors that form from hormone-releasing cells.

  • William Robinson, pioneering virologist

    Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.

  • Synthetic biology and sustainability

    Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.

  • Nobelists credit basic research

    A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.

  • Cyclotron director dies at 43

    The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.

  • Nobelist Paul Berg dies

    Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

  • Bertozzi research advances medicine

    Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.

  • Magazine explores molecules within us

    The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.

  • Therapeutics accelerator launched

    Deerfield Management, a health care investment firm, has committed up to $130 million to support innovative translational research at Stanford.

  • $31 million for stem cell clinical trials

    The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.

  • Drug Discovery Symposium runs April 19-20

    The annual conference will feature an interdisciplinary cast of researchers, industry leaders and policymakers who will discuss advances in therapeutics, including COVID-19 treatments.


Related Websites